Publications found:
28,600
Sort by:
Global Erythropoietin Drugs Market Size study, By Drug Class (Biologics, Biosimilars), By Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others), By Application (Cancer, Hematology, Neurology and Renal Diseases) and Regional Forecasts 2021-2027
US$ 3,000.00
Global Erythropoietin Drugs Market is valued approximately USD 11.05 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 11.30% over the forecast period 2021-2027. Eryth...
June 2021
200 pages
Global Vitamin D Therapy Market Size study, by Route of administration (Oral and Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases and Others) and Regional Forecasts 2021-2027
US$ 3,000.00
Global Vitamin D Therapy Market is valued approximately USD 2.11 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 11.3% over the forecast period 2021-2027. Vitamin D...
June 2021
200 pages
Pharmaceutical Caps and Closures Market Size study, by Product Type (Screw-on Caps, Dispensing Caps and Others) by Technology (Injection Moulding, Compression Moulding, Post-mould TE Band, Others) By Raw Material (PP, HDPE, LDPE and others), By End-use (Beverage, Pharmaceuticals and others) and Regional Forecasts 2021-2027.
US$ 3,000.00
Global Pharmaceutical Caps and Closures Market is valued at approximately USD 34.50 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 5.4% over the forecast period 202...
June 2021
200 pages
Investigation Report on China's Docetaxel Market 2021-2025
US$ 2,600.00
Docetaxel, sold under the brand name Taxotere, is a paclitaxel anti-tumor drug used for the treatment of locally advanced or metastatic non-small cell lung cancer. Docetaxel injection was first develo...
June 2021
50 pages
Investigation Report on China's Omalizumab Market 2021-2025
US$ 2,600.00
Omalizumab, developed by Novartis Europharm, is the only approved antibody designed to target and block immunoglobulin E (IgE). At the end of 2017, the FDA approved the registration of Novartis Europh...
June 2021
50 pages
Investigation Report on China's Pertuzumab Market 2021-2025
US$ 2,600.00
Pertuzumab is the first monoclonal antibody called 'HER dimerization inhibitor'. It mainly used to treat HER2-positive breast cancer. It was developed by Genentech, a subsidiary of Roche Pharma (Schwe...
June 2021
50 pages
Drug Discovery Informatics - Global Market Outlook (2020-2028)
US$ 4,150.00
... Drug Discovery Informatics market. However, Lack of information technology and critical attributes of data evaluation are limiting the market growth. The recent trends in Drug Discovery Informatics are considerable shift observed from traditional in-vitro drug development to computer aided drug designing, as costly failures of late drug development increases ...
June 2021
150 pages
Acne vulgaris - Pipeline Insight, 2021
US$ 2,000.00
... clients within 5 Days 'Acne Vulgaris - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Acne Vulgaris development. The report provides ...
June 2021
70 pages
Angina pectoris - Pipeline Insight, 2021
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Angina (Angina Pectoris) The report also ...
June 2021
60 pages
Cachexia - Pipeline Insight, 2021
US$ 2,000.00
... clients within 48 Hours 'Cachexia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cachexia development. The report provides detailed ...
June 2021
80 pages
Diabetic foot ulcer - Pipeline Insight, 2021
US$ 2,000.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Diabetic Foot Ulcers The report also ...
June 2021
80 pages
Pruritus - Pipeline Insight, 2021
US$ 2,000.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Pruritus - Pipeline Insight, 2019 The report also ...
June 2021
90 pages
Vulvovaginal candidiasis - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Vulvovaginal Candidiasis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Vulvovaginal Candidiasis development. The report provides ...
June 2021
60 pages
Post-traumatic stress disorders - Pipeline Insight, 2021
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Post-Traumatic Stress Disorder (PTSD) The report also ...
June 2021
60 pages
Urea cycle disorders - Pipeline Insight, 2021
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Urea Cycle Disorders The report also ...
June 2021
60 pages
Adenoid cystic carcinoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Adenoid cystic carcinoma - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipe...
June 2021
60 pages
Allergic rhinitis - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Allergic rhinitis - Pipeline Insight, 2021,” report provides comprehensive insights about 35+ companies and 35+ pipeline...
June 2021
90 pages
Diffuse large B cell lymphoma - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Diffuse large B cell lymphoma - Pipeline Insight, 2021,” report provides comprehensive insights about 80+ companies and 8...
June 2021
60 pages
Migraine - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Migraine - Pipeline Insight, 2021,” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in...
June 2021
60 pages
Pancreatic Cancer - Pipeline Insight, 2021
US$ 3,000.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Pancreatic Cancer - Pipeline Insight, 2021,” report provides comprehensive insights about 100+ companies and 100+ pipelin...
June 2021
60 pages
Global Ibuprofen Market, By Product Type (Tablet, Capsule, Syrup and Injection), By Route of Administration (Oral v/s Intravenous), By Application (Rheumatoid Arthritis and Osteoarthritis, Ankylosing Spondylitis, Inflammatory Diseases, Dysmenorrhea, Others), By Age Group (Adult v/s Pediatric), By Source (Contract Manufacturing Organizations (CMO), In-House), By End User (Hospitals, Clinics, Others), By Distribution Channel (Offline v/s Online), By Region, Competition Forecast & Opportunities, 2026
US$ 4,500.00
The global ibuprofen market is expected to grow at a steady rate during the forecast period with a CAGR of 5.67% in value terms to reach USD6945.36 million by 2026. The global ibuprofen market is driv...
June 2021
118 pages
Anorexia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Anorexia - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in An...
June 2021
60 pages
Glabellar lines - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Glabellar lines - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drug...
June 2021
60 pages
Gonorrhoea - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Gonorrhoea - Pipeline Insight, 2021,” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs i...
June 2021
60 pages
Hypercholesterolaemia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Hypercholesterolaemia - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipel...
June 2021
60 pages
Hypertrophic cardiomyopathy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Hypertrophic cardiomyopathy - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ p...
June 2021
60 pages
Malaria - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Malaria - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in M...
June 2021
60 pages
Nosocomial pneumonia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Nosocomial pneumonia - Pipeline Insight, 2021,” report provides comprehensive insights about 13+ companies and 15+ pipeli...
June 2021
60 pages
Obesity - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Obesity - Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in O...
June 2021
60 pages
Richter’s syndrome - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Richter’s syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline d...
June 2021
60 pages
Scars - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Scars - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Sca...
June 2021
60 pages
Tuberculosis - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Tuberculosis - Pipeline Insight, 2021,” report provides comprehensive insights about 35+ companies and 35+ pipeline drugs...
June 2021
60 pages
